Floatz logo

(+)-VINCRISTINE

Ovarian Diseases

Xiaoxiang ChenSmall moleculePhase 3Active
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Ovarian Diseases cohort.

Asset / SponsorPhaseRating
Carboplatin
Fujian Cancer Hospital
Phase 3BB
Temsirolimus
AGO Study Group
Phase 2B
DEXAMETHASONE
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 2B
Trabectedin
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 2B
LENVATINIB
Sheba Medical Center
Phase 2CCC

View all 14 →

Same molecule, other indications

(+)-VINCRISTINE is also rated in:

anaplastic large cell lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →